Healthcare and Pharmaceuticals industry

Renal Diseases Drug Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Renal Diseases Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Renal Diseases Drug Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Renal Diseases Drug Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Pfizer
  • Amgen
  • Roche
  • GlaxoSmithKline (GSK)
  • Allergan
  • AbbVie
  • Kissei Pharmaceutical
  • AstraZeneca
  • FibroGen
  • Sanofi
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Keryx Biopharmaceuticals

By the Product Type, the market is primarily segmented into:

  • Chronic Kidney Disease (CKD) Drugs
  • End-Stage Kidney Disease (ESRD) Drugs

By Applications, the market is segmented into:

  • Hospitals
  • Specialty Clinics
  • Other

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Renal Diseases Drug Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Renal Diseases Drug Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Renal Diseases Drug Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Renal Diseases Drug Market

The Renal Diseases Drug Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Renal Diseases Drug Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Renal Diseases Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Chronic Kidney Disease (CKD) Drugs
1.4.3 End-Stage Kidney Disease (ESRD) Drugs
1.5 Market by Application
1.5.1 Global Renal Diseases Drug Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Renal Diseases Drug Market Size
2.2 Renal Diseases Drug Growth Trends by Regions
2.2.1 Renal Diseases Drug Market Size by Regions (2019-2025)
2.2.2 Renal Diseases Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis

3 Market Share by Key Players
3.1 Renal Diseases Drug Market Size by by Players
3.1.1 Global Renal Diseases Drug Revenue by by Players (2014-2019)
3.1.2 Global Renal Diseases Drug Revenue Market Share by by Players (2014-2019)
3.1.3 Global Renal Diseases Drug Market Concentration Ratio (CR5 and HHI)
3.2 Renal Diseases Drug Key Players Head office and Area Served
3.3 Key Players Renal Diseases Drug Product/Solution/Service
3.4 Date of Enter into Renal Diseases Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Renal Diseases Drug Market Size by Type (2014-2019)
4.2 Global Renal Diseases Drug Market Size by Application (2014-2019)

5 North America
5.1 North America Renal Diseases Drug Market Size (2014-2019)
5.2 Renal Diseases Drug Key Players in North America
5.3 North America Renal Diseases Drug Market Size by Type
5.4 North America Renal Diseases Drug Market Size by Application

6 Europe
6.1 Europe Renal Diseases Drug Market Size (2014-2019)
6.2 Renal Diseases Drug Key Players in Europe
6.3 Europe Renal Diseases Drug Market Size by Type
6.4 Europe Renal Diseases Drug Market Size by Application

7 China
7.1 China Renal Diseases Drug Market Size (2014-2019)
7.2 Renal Diseases Drug Key Players in China
7.3 China Renal Diseases Drug Market Size by Type
7.4 China Renal Diseases Drug Market Size by Application

8 Japan
8.1 Japan Renal Diseases Drug Market Size (2014-2019)
8.2 Renal Diseases Drug Key Players in Japan
8.3 Japan Renal Diseases Drug Market Size by Type
8.4 Japan Renal Diseases Drug Market Size by Application

9 International Players Profiles
9.1 Pfizer
9.1.1 Pfizer Company Details
9.1.2 Company Description and Business Overview
9.1.3 Renal Diseases Drug Introduction
9.1.4 Pfizer Revenue in Renal Diseases Drug Business (2014-2019))
9.1.5 Pfizer Recent Development
9.2 Amgen
9.2.1 Amgen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Renal Diseases Drug Introduction
9.2.4 Amgen Revenue in Renal Diseases Drug Business (2014-2019)
9.2.5 Amgen Recent Development
9.3 Roche
9.3.1 Roche Company Details
9.3.2 Company Description and Business Overview
9.3.3 Renal Diseases Drug Introduction
9.3.4 Roche Revenue in Renal Diseases Drug Business (2014-2019)
9.3.5 Roche Recent Development
9.4 GlaxoSmithKline (GSK)
9.4.1 GlaxoSmithKline (GSK) Company Details
9.4.2 Company Description and Business Overview
9.4.3 Renal Diseases Drug Introduction
9.4.4 GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2014-2019)
9.4.5 GlaxoSmithKline (GSK) Recent Development
9.5 Allergan
9.5.1 Allergan Company Details
9.5.2 Company Description and Business Overview
9.5.3 Renal Diseases Drug Introduction
9.5.4 Allergan Revenue in Renal Diseases Drug Business (2014-2019)
9.5.5 Allergan Recent Development
9.6 AbbVie
9.6.1 AbbVie Company Details
9.6.2 Company Description and Business Overview
9.6.3 Renal Diseases Drug Introduction
9.6.4 AbbVie Revenue in Renal Diseases Drug Business (2014-2019)
9.6.5 AbbVie Recent Development
9.7 Kissei Pharmaceutical
9.7.1 Kissei Pharmaceutical Company Details
9.7.2 Company Description and Business Overview
9.7.3 Renal Diseases Drug Introduction
9.7.4 Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2014-2019)
9.7.5 Kissei Pharmaceutical Recent Development
9.8 AstraZeneca
9.8.1 AstraZeneca Company Details
9.8.2 Company Description and Business Overview
9.8.3 Renal Diseases Drug Introduction
9.8.4 AstraZeneca Revenue in Renal Diseases Drug Business (2014-2019)
9.8.5 AstraZeneca Recent Development
9.9 FibroGen
9.9.1 FibroGen Company Details
9.9.2 Company Description and Business Overview
9.9.3 Renal Diseases Drug Introduction
9.9.4 FibroGen Revenue in Renal Diseases Drug Business (2014-2019)
9.9.5 FibroGen Recent Development
9.10 Sanofi
9.10.1 Sanofi Company Details
9.10.2 Company Description and Business Overview
9.10.3 Renal Diseases Drug Introduction
9.10.4 Sanofi Revenue in Renal Diseases Drug Business (2014-2019)
9.10.5 Sanofi Recent Development
9.11 Teva Pharmaceutical Industries
9.12 Johnson & Johnson
9.13 Keryx Biopharmaceuticals

10 Market Forecast 2019-2025
10.1 Market Size Forecast by Product (2019-2025)
10.2 Market Size Forecast by Application (2019-2025)
10.3 Market Size Forecast by Regions
10.4 North America
10.5 Europe
10.6 China
10.7 Japan

11 Analyst's Viewpoints/Conclusions

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

List of Table
List of Tables and Figures

Table Renal Diseases Drug Key Market Segments
Table Key Players Renal Diseases Drug Covered
Table Global Renal Diseases Drug Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Chronic Kidney Disease (CKD) Drugs Figures
Table Key Players of Chronic Kidney Disease (CKD) Drugs
Figuer End-Stage Kidney Disease (ESRD) Drugs Figures
Table Key Players of End-Stage Kidney Disease (ESRD) Drugs
Table Global Renal Diseases Drug Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Renal Diseases Drug Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Specialty Clinics Case Studies
Figure Other Case Studies
Figure Renal Diseases Drug Report Years Considered
Figure Global Renal Diseases Drug Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Renal Diseases Drug Market Size by Regions 2019-2025 (Million US$)
Table Global Renal Diseases Drug Market Size by Regions 2019-2025 (Million US$)
Table Global Renal Diseases Drug Market Share by Regions 2014-2019
Figure Global Renal Diseases Drug Market Share by Regions 2014-2019
Figure Global Renal Diseases Drug Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Renal Diseases Drug Revenue by by Players (2014-2019) (Million US$)
Table Global Renal Diseases Drug Market Share by by Players (2014-2019)
Figure Global Renal Diseases Drug Market Share by by Players in 2018
Table Global Renal Diseases Drug by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Renal Diseases Drug Product/Solution/Service
Table Date of Enter into Renal Diseases Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Renal Diseases Drug Market Size by Type (2014-2019) (Million US$)
Table Global Renal Diseases Drug Market Size Share by Type (2014-2019)
Figure Global Renal Diseases Drug Market Size Market Share by Type (2014-2019)
Table Global Renal Diseases Drug Market Size by Application (2014-2019) (Million US$)
Table Global Renal Diseases Drug Market Size Share by Application (2014-2019)
Figure Global Renal Diseases Drug Market Size Market Share by Application (2014-2019)
Figure Global Renal Diseases Drug Revenue Market Share by Application in 2018
Figure North America Renal Diseases Drug Market Size 2014-2019 (Million US$)
Table North America Key Players Renal Diseases Drug Revenue (2018-2019) (Million US$)
Table North America Key Players Renal Diseases Drug Market Share (2018-2019)
Table North America Renal Diseases Drug Market Size by Type 2014-2019 (Million US$)
Table North America Renal Diseases Drug Market Share by Type 2014-2019
Table North America Renal Diseases Drug Market Size by Application 2014-2019 (Million US$)
Table North America Renal Diseases Drug Market Share by Application 2014-2019
Figure Europe Renal Diseases Drug Market Size 2014-2019 (Million US$)
Table Europe Key Players Renal Diseases Drug Revenue (2018-2019) (Million US$)
Table Europe Key Players Renal Diseases Drug Market Share (2018-2019)
Table Europe Renal Diseases Drug Market Size by Type 2014-2019 (Million US$)
Table Europe Renal Diseases Drug Market Share by Type 2014-2019
Table Europe Renal Diseases Drug Market Size by Application 2014-2019 (Million US$)
Table Europe Renal Diseases Drug Market Share by Application 2014-2019
Figure China Renal Diseases Drug Market Size 2014-2019 (Million US$)
Table China Key Players Renal Diseases Drug Revenue (2018-2019) (Million US$)
Table China Key Players Renal Diseases Drug Market Share (2018-2019)
Table China Renal Diseases Drug Market Size by Type 2014-2019 (Million US$)
Table China Renal Diseases Drug Market Share by Type 2014-2019
Table China Renal Diseases Drug Market Size by Application 2014-2019 (Million US$)
Table China Renal Diseases Drug Market Share by Application 2014-2019
Figure Japan Renal Diseases Drug Market Size 2014-2019 (Million US$)
Table Japan Key Players Renal Diseases Drug Revenue (2018-2019) (Million US$)
Table Japan Key Players Renal Diseases Drug Market Share (2018-2019)
Table Japan Renal Diseases Drug Market Size by Type 2014-2019 (Million US$)
Table Japan Renal Diseases Drug Market Share by Type 2014-2019
Table Japan Renal Diseases Drug Market Size by Application 2014-2019 (Million US$)
Table Japan Renal Diseases Drug Market Share by Application 2014-2019
Table Pfizer Company Details
Table Pfizer Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure Amgen Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table Amgen Recent Development
Table Roche Company Details
Table Roche Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table Roche Recent Development
Table GlaxoSmithKline (GSK) Company Details
Table GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure GlaxoSmithKline (GSK) Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table GlaxoSmithKline (GSK) Recent Development
Table Allergan Company Details
Table Allergan Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure Allergan Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table Allergan Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table AbbVie Recent Development
Table Kissei Pharmaceutical Company Details
Table Kissei Pharmaceutical Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure Kissei Pharmaceutical Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table Kissei Pharmaceutical Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table AstraZeneca Recent Development
Table FibroGen Company Details
Table FibroGen Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure FibroGen Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table FibroGen Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Renal Diseases Drug Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Renal Diseases Drug Business (2014-2019)
Table Sanofi Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Johnson & Johnson Company Details
Table Keryx Biopharmaceuticals Company Details
Table Global Renal Diseases Drug Market Size by Regions (Million US$) 2019-2025
Figure Global Renal Diseases Drug Market Size Share by Regions (2019-2025)
Figure Global Renal Diseases Drug Market Size Share by Regions in 2025
Figure North America Renal Diseases Drug Market Size Forecast (2019-2025)(Million USD)
Figure Europe Renal Diseases Drug Market Size Forecast (2019-2025)(Million USD)
Figure China Renal Diseases Drug Market Size Forecast (2019-2025)(Million USD)
Figure Japan Renal Diseases Drug Market Size Forecast (2019-2025)(Million USD)
Table Global Renal Diseases Drug Market Size by Product (2019-2025) (Million US$)
Figure Global Renal Diseases Drug Market Size by Product (2019-2025)
Figure Global Renal Diseases Drug Market Size by Product in 2025
Table Global Renal Diseases Drug Market Size by Application (2019-2025) (Million US$)
Figure Global Renal Diseases Drug Market Size by Application (2019-2025)
Figure Global Renal Diseases Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 



Contact Us

U.S.A :  +1-415-871-0703

UK :  +44-203-289-4040

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.